Skip to main content
Clinical Trials/JPRN-UMIN000052582
JPRN-UMIN000052582
Recruiting
未知

Examination of therapeutic efficacy after changing faricimab for patients with wet age-related macular degeneration using existing anti-VEGF drugs - Efficacy of treatment after changing faricimab for wet AMD

kagawa university0 sites100 target enrollmentOctober 23, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
wet age-related macular degeneration
Sponsor
kagawa university
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 23, 2023
End Date
July 31, 2027
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Greatest Linear Dimension (GLD) of the total lesion area \<12 Macular Photocoagulation Study Disc Areas 2\) Presence of subretinal hemorrhage, scar or macular fibrosis (\>50% lesion area) 3\) Prior treatment with dexamethasone (\<6 months) or triamcinolone (\<30 days), intraocular surgery (\<3 months) 4\) Active intraocular inflammation 5\) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 6\) Patient who the doctor in charge judges are ineligible for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials